Table S1-S5, Figure S1-S12 from Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer
Kota Ishioka(Keio University), Koichi Fukunaga(Keio University), Kenzo Soejima(Keio University), Takashi Kamatani(Tokyo Medical and Dental University), Katsuya Tsuchihara(Chiba Cancer Center), Toshiki Ebisudani(Keio University), Hideo Watanabe(St. Catherine University), Mari Ozaki(Keio University), Takashi Kohno(Gunma University), Tetsuo Tani(Seirei Christopher University), Ahmed E. Hegab(Keio University), Keita Masuzawa(Kitasato Institute Hospital), Shinnosuke Ikemura(Keio University), Keiko Ohgino(Keio University), Sachiyo Mimaki(Translational Research in Oncology), Tae Jung Kim(The Catholic University of Korea Yeouido St. Mary's Hospital), Akifumi Mitsuishi(Keio University), Shigemichi Hirose(Keio University), Hideki Terai(Kitasato Institute Hospital), Takashi Ohtsuka(Keio University), Hisao Asamura(Keio University), Susumu Kobayashi(Harvard University), Taro Shinozaki(Keio University), Morio Nakamura(Saiseikai Central Hospital), Tomoko Betsuyaku(Tokyo Medical University), Daisuke Arai(Keio University), Katsura Emoto(Keio University), Hiroyuki Yasuda(Beth Israel Deaconess Medical Center), Junko Hamamoto(Keio University), Ichiro Kawada(Keio University), Katsuhiko Naoki(Broad Institute), David M. Ornitz(Washington University in St. Louis), Takahiro Fukushima, Tadashi Manabe(Keio University)
Cited by 0
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
|Cell|1991|2.4k
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
Murine FGFR-1 is required for early postimplantation growth and axial organization.
|Genes & Development|1994|748